Healthcare resource utilization and costs among treatment-naïve people with HIV in state Medicaids: analysis of multi-tablet vs. single-tablet antiretroviral regimen initiators with and without concurrent mental health disorders

Among PWH/MHD and PWH/no-MHD, MTR-initiators experienced significantly higher HCRU, and 1.5 times greater costs compared to STR-initiators. In both MTR and STR-initiator groups, the PWH/MHD cohort consistently demonstrated a greater HCRU and cost burden than the PWH/no-MHD.

Authors

Institutions

Publication Details

Journal
Journal of Medical Economics
Published
2024-12-04
DOI
https://doi.org/10.1080/13696998.2024.2436288
Citations
3
Primary Topic
HIV/AIDS Research and Interventions
Type
article
Field-Weighted Citation Impact
1.17
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Healthcare resource utilization and costs among treatment-naïve people with HIV in state Medicaids: analysis of multi-tablet vs. single-tablet antiretroviral regimen initiators with and without concurrent mental health disorders

Mary J. Christoph, Krithika Rajagopalan, Melissa Chen, J. Gruber et al.
3 citations
Journal of Medical Economics
HIV/AIDS Research and Interventions
1.17
article

Healthcare resource utilization and costs among treatment-naïve people with HIV in state Medicaids: analysis of multi-tablet vs. single-tablet antiretroviral regimen initiators with and without concurrent mental health disorders

Mary J. Christoph, Krithika Rajagopalan, Melissa Chen, J. Gruber, Amy R. Weinberg, F. Turkistani, W. Zachry, C. Trom, Sungha Park, Uche Mordi
article en
3 citations

Abstract

Among PWH/MHD and PWH/no-MHD, MTR-initiators experienced significantly higher HCRU, and 1.5 times greater costs compared to STR-initiators. In both MTR and STR-initiator groups, the PWH/MHD cohort consistently demonstrated a greater HCRU and cost burden than the PWH/no-MHD.

Journal of Medical EconomicsVol. 28(1)
Office of Patient Care Services (US), Health Economics and Outcomes Research (United Kingdom) (GB), Gilead Sciences (United States) (US), Gilead Sciences (Australia) (AU), Ab Analitica (Italy) (IT)
Openalex Percentile: Top 20%
HIV/AIDS Research and Interventions
1.17
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Healthcare resource utilization and costs among treatment-naïve people with HIV in state Medicaids: analysis of multi-tablet vs. single-tablet antiretroviral regimen initiators with and without concurrent mental health disorders — Mary J. Christoph, Krithika Rajagopalan, et al. · Journal of Medical Economics (2024) | TGRS Research Map | TGRS